LIVN Livanova Plc
Data as of close
Healthcare · Electromedical & Electrotherapeutic Apparatus
Livanova Plc (LIVN) is a healthcare company in the Electromedical & Electrotherapeutic Apparatus industry, with a market capitalization of $4.4 billion. Shares last traded at $80.20, 7.6% below their 52-week high. Over the past year the stock is up 52.0%. LIVN trades at a price-to-earnings ratio of 23.44, in line with the Electromedical & Electrotherapeutic Apparatus median of 23.44. Net profit margin is 12.8%, above the peer median of -10.0%. Revenue grew 10.7% year over year.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $1.93 | 2026-08-05 |
| Q1 2026 | $0.40 | 2026-05-06 |
| Q4 2025 (derived) | $0.57 | 2026-02-25 |
| FY 2025 | -$4.45 | 2026-02-25 |
| Q3 2025 | $0.49 | 2025-11-05 |
| Q2 2025 | $0.50 | 2025-08-06 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Electromedical & Electrotherapeutic Apparatus peers
LIVN vs 14 industry peers (Electromedical & Electrotherapeutic Apparatus), by market cap. Data as of close
| MDT | Medtronic | $127.0B | 24.28 | 3.38 | 13.9% | +2.86% |
| LIVN | Livanova Plc | $4.4B | 23.44 | 3.00 | 12.8% | +1.58% |
| ITGR | Integer Holdings Corp | $4.3B | 41.50 | 2.36 | 5.7% | -0.02% |
| AXGN | Axogen, Inc. | $3.0B | — | 11.16 | -12.0% | +0.97% |
| TMDX | Transmedics Group, Inc. | $2.3B | 15.21 | 3.45 | 22.7% | +1.05% |
| CNMD | Conmed Corp | $1.4B | 29.48 | 1.01 | 3.4% | +5.20% |
| CBLL | Ceribell, Inc. | $1.0B | — | 10.15 | -64.7% | +1.51% |
| INMD | Inmode Ltd. | $867M | 9.24 | 2.34 | 25.3% | +3.56% |
| CV | CapsoVision, Inc | $337M | — | — | — | -1.32% |
| ELMD | Electromed, Inc. | $224M | 19.85 | 3.04 | 15.3% | -0.28% |
| FOCL | EDAP TMS SA | $161M | — | 2.29 | -41.5% | +2.26% |
| VANI | Vivani Medical, Inc. | $99M | — | 207.94 | — | +0.00% |
| STXS | Stereotaxis, Inc. | $88M | — | 2.93 | -74.2% | +2.76% |
| NRXS | Neuraxis, INC | $84M | — | — | — | -6.91% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.